Bai Mei
Endocrine-Hypertension Division and Membrane Biology Program, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Cell Signal. 2004 Feb;16(2):175-86. doi: 10.1016/s0898-6568(03)00128-1.
Recently, many G-protein-coupled receptors (GPCRs) have been demonstrated to form constitutive dimers consisting of identical or distinct monomeric subunits. The discovery of GPCR dimerization has revealed a new level of molecular cross-talk between signalling molecules and may define a general mechanism that modulates the function of GPCRs under both physiological and pathological conditions. The heterodimerization between distinct GPCRs could be responsible for the generation of pharmacologically defined receptors for which no gene has been identified so far. Elucidating the role of dimerization in the activation processes of GPCRs will lead us to develop novel pharmaceutical agents that allosterically promote activation or inhibition of GPCR signalling.
最近,许多G蛋白偶联受体(GPCRs)已被证明能形成由相同或不同单体亚基组成的组成型二聚体。GPCR二聚化的发现揭示了信号分子之间分子串扰的一个新层面,并可能定义一种在生理和病理条件下调节GPCR功能的通用机制。不同GPCR之间的异源二聚化可能是产生迄今尚未鉴定出基因的药理学定义受体的原因。阐明二聚化在GPCR激活过程中的作用将引导我们开发能变构促进或抑制GPCR信号传导的新型药剂。